MedPath

Clinical Investigation Comparing Two Different Ultra-porous Coated Surfaces of Uncemented Cups

Not Applicable
Active, not recruiting
Conditions
Osteoarthritis, Hip
Registration Number
NCT05773261
Lead Sponsor
Umeå University
Brief Summary

A randomised controlled study comparing two types of ultra-porous coated uncemented cups in total hip arthroplasty. Primary objective is to investigate if the clinical, radiological and patient-reported outcome of the new MobileLINK TabecuLINK cup combined with an X-LINKed insert is non-inferior to the clinical and radiological outcome of the Pinnacle Gription series 100 cup combined with the Marathon liner. Patients are evaluated up to 15 years postoperatively.

Detailed Description

The purpose of this study is to evaluate the clinical outcome and long-term risk of development of osteolysis of a newly introduced cementless press-fit acetabular cup, consisting of a shell with a 3D surface structure and a highly cross-linked liner by precise measurement of early migration and wear.

Migration describes the movement between the implant and the surrounding bone over time. Early migration of the implant, within 2 years after operation, has shown to be a strong predictor for increased risk for late failure. Thus, high precision migration studies can be used to evaluate the performance of new implants in small groups of patients with a relatively short observation time. Wear particles are one of the main causes of periprosthetic osteolysis. Although modern, more wear resistant materials, appears to have a greatly reduced risk of osteolysis, the desired complete elimination of osteolysis appears to be yet unachieved. It is most likely that the mechanism of periprosthetic osteolysis is multifactorial.

In this study the investigators plan to include 70 patients that are planned for operation with an uncemented total hip arthroplasty. 35 patients will be randomized to receive the new implant and 35 patients will be included in the control group and receive a standard uncemented prosthesis. All patients will then be followed with CT scans and patient reported outcome measures 3-month, 1 year, 2 years, 5 years and 15 years after the operations. The CT scans will be used both for measurement of migration and wear and development of osteolysis around the implant.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Patients are foreseen for implantation of an uncemented acetabular press-fit cup and an uncemented stem
  • Age 30-70 years
  • Primary osteoarthritis of the hip
  • Body Mass Index between 18 and 35 kg/m2
  • Willingness and ability to follow clinical investigation protocol
Exclusion Criteria
  • Grossly abnormal hip anatomy (hip dysplasia, Crowe Grade 2 or above, Perthes or other causes)
  • Osteoporosis
  • Paget's disease
  • Inflammatory arthritis
  • Secondary osteoarthritis
  • Presence of malignancy in the area of surgery
  • Treatment with bisphosphonates, cortisol or cytostatic drugs 6 months or less prior to surgery
  • Previous surgery in the affected hip
  • Inclusion of the contralateral hip in this clinical investigation
  • Not suited for the clinical investigation for other reason (surgeon's judgment)
  • Pregnant or breastfeeding women
  • Prison inmate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Early migration of the cup2 years after operation

Migration of the cup between 3 month and 2 years after implantation of the cup measured with Computed Tomography scan based Micromotion Analysis (CTMA) in mm.

Secondary Outcome Measures
NameTimeMethod
Long term wear15 years after operation

Liner wear measured in mm with CTMA

Patient reported outcome with Forgotten Joint Score15 years after operation

Patient-reported outcome measured by Forgotten Joint Score (FSJ). The scores will be summarized and transformed to a scale ranging from 0 to 100, where a high value indicate that the patient tends to be less aware of the affected joint when performing daily activities.

Reoperations15 years after operation

Incidence and rate of revisions, re-operations and operation-related complications

Osteolysis15 years after operation

Incidence and rate of patients showing osteolysis around the cup on CT scans and/or on x-rays

Proximal wear5 years after operation

Liner wear measured as proximal penetration of the femoral head prosthesis into the liner between 1 year and 5 years after operation in mm

3D wear5 years after operation

Liner wear measured as 3D penetration of the femoral head prosthesis into the liner between 1 year and 5 years after operation in mm

Stem migration15 years

Distal and 3D migration in mm of the stem between post- operative examination and 3 month, 3 month and 2 years, 3 month and 5 years and 3 month and 15 years.

Precision of migration measurements with CTMA1 year after operation

Precision of migration measurement in mm with CTMA, by comparing double CT scans obtained on the same day at the 1 year follow-up.

Long term migratio15 years after operation

Migration of the cup measured in mm with CTMA

Patient reported outcome with Hip dysfunction and Osteoarthritis Outcome Score15 years after operation

Patient-reported outcome measured by Hip dysfunction and Osteoarthritis Outcome Score (HOOS). Each of the 5 subscales will get a score of 0 to 100, with 0 indicating extreme symptoms and 100 indicating no symptoms. The subscales will be plotted as a HOOS profile, by connecting the mean scores for all 5 dimensions with a line.

Patient reported outcome with University of California, Los Angeles Activity Score15 years after operation

Patient-reported outcome measured by University of California, Los Angeles Activity Score (UCLA). The patients physical activity level rank from 1 (low) to 10 (high).

Patient reported outcome with EuroQuol 5.15 years after operation

Patient reported health related quality of life, measured by EuroQuol 5 dimensions (EQ-5D). For the calculation of the EQ-5D index the standard value set version 2.1 for Sweden is used. Index scores range from 0 ( 0 is the value of a health state equivalent to dead; negative values representing values as worse than dead) to 1 (the value of full health), with higher scores indicating higher health utility.

Precision of wear mearurements with CTMA1 year after operation

Precision of wear measurement in mm with CTMA, by comparing double CT scans obtained on the same day at the 1 year follow-up.

Trial Locations

Locations (1)

Volker Otten

🇸🇪

Umeå, Västerbotten, Sweden

Volker Otten
🇸🇪Umeå, Västerbotten, Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.